Asensus Surgical (FRA:2TX) EV-to-EBIT : -0.88 (As of May. 21, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Asensus Surgical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Asensus Surgical's Enterprise Value is €60.29 Mil. Asensus Surgical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-68.54 Mil. Therefore, Asensus Surgical's EV-to-EBIT for today is -0.88.

The historical rank and industry rank for Asensus Surgical's EV-to-EBIT or its related term are showing as below:

FRA:2TX' s EV-to-EBIT Range Over the Past 10 Years
Min: -25.78 Med: -2.38 Max: 0.17
Current: -0.88

During the past 13 years, the highest EV-to-EBIT of Asensus Surgical was 0.17. The lowest was -25.78. And the median was -2.38.

FRA:2TX's EV-to-EBIT is ranked worse than
100% of 457 companies
in the Medical Devices & Instruments industry
Industry Median: 20.17 vs FRA:2TX: -0.88

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Asensus Surgical's Enterprise Value for the quarter that ended in Mar. 2024 was €53.70 Mil. Asensus Surgical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-68.54 Mil. Asensus Surgical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -127.63%.

Asensus Surgical EV-to-EBIT Historical Data

The historical data trend for Asensus Surgical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asensus Surgical EV-to-EBIT Chart

Asensus Surgical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-0.14

-0.99

-2.72

-0.23

-0.88

Asensus Surgical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															-1.36	-1.09	-0.55	-0.88	-0.81

Competitive Comparison of Asensus Surgical's EV-to-EBIT

For the Medical Devices subindustry, Asensus Surgical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Asensus Surgical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Asensus Surgical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Asensus Surgical's EV-to-EBIT falls into.

Asensus Surgical EV-to-EBIT Calculation

Asensus Surgical's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	60.287	/	-68.536
	=	-0.88

Asensus Surgical's current Enterprise Value is €60.29 Mil.
Asensus Surgical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-68.54 Mil.

Asensus Surgical (FRA:2TX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Asensus Surgical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	-68.536	/	53.699116
	=	-127.63 %

Asensus Surgical's Enterprise Value for the quarter that ended in Mar. 2024 was €53.70 Mil.
Asensus Surgical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-68.54 Mil.

Asensus Surgical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Asensus Surgical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Asensus Surgical (FRA:2TX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Asensus Surgical Inc (FRA:2TX) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

ASXC:USA

Address

1 TW Alexander Drive, Suite 160, Durham, NC, USA, 27703

Website

https://www.asensus.com

Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.

Asensus Surgical (FRA:2TX) Headlines

No Headlines